Russia-based CRO partners with Japanese distributor
EDASA Scientific has partnered with Namiki Shoji Co., a Japanese company distributing drug discovery compounds and intermediates to the pharmaceutical industry.
Archives for October 31, 2017
news in brief
US FDA bans APIs made by Fleming Labs
Fleming Laboratories has been banned from shipping APIs to the US by the FDA which says its manufacturing plant in Nawabpet, Telangana in India is not up to code.
PPD extends long-standing NIH collaboration
The National Institute of Health (NIH) has awarded Pharmaceutical Product Development, LLC (PPD) a seven-year contract for clinical research support services.
Daiichi Sankyo inks Glycotope ADC deal
Daiichi Sankyo Company has signed an option agreement to develop Glycotope’s antibody drug conjugate (ADC) to target various cancers including ovarian, lung and breast tumours.
Novartis to pay $3.9 bn for radiopharma drug & biz
Novartis has announced plans to buy radiopharmaceutical firm Advanced Accelerator Applications (AAA), which will add neuroendocrine tumour treatment Lutathera to its portfolio.
Shire to sell Milford facility
Shire expects to be making some Cinryze in-house early next year
Shire has said it is on track to start making some Cinryze in-house next year to address supply problems at Dutch contractor Sanquin.